BCR/ABL1 p210 Quantitative PCR Blood
Test Mnemonic
P210PB
CPT Codes
- 81206 - QTY (1)
Aliases
- BCRABL
- Chronic Myeloid Leukemia
- CML
- Minimal Residual Disease
- p210
- PCR
- quantitative
Performing Laboratory
Cleveland Clinic Laboratories
FDA Category
In Vitro Diagnostic
Specimen Requirements
Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
---|---|---|---|---|---|
10 mL | Whole blood | EDTA (Lavender) | Ambient | Ambient | If patient has low white blood cell count, please collect up to an additional 10mL in EDTA (Lavender) and forward all tubes to performing lab. |
Minimum Specimen Requirements
Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
---|---|---|---|---|---|
4 mL |
Stability
Environmental Condition | Description |
---|---|
Ambient | 48 hours |
Refrigerated | 7 Days |
Frozen | Unacceptable |
Days Performed
5 days per week
Turnaround Time
5 days
Methodology
Name | Description |
---|---|
Polymerase Chain Reaction (PCR), Quant |
Special Info
Clearly indicate specimen type on label. External client shipping instructions: Ship “Priority Overnight;” do not ship on Fridays or the day preceding a holiday.
Clinical Limitation
This assay is designed to detect, but not distinguish between the BCR/ABL1 fusion transcripts e13a2 (b2a2) and e14a2 (b3a2). This assay does not detect minor or micro breakpoints, microdeletions, or mutations.